A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India

NCT04153981 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company